Ronald Blue Trust, Inc. Neogenomics Inc Transaction History
Ronald Blue Trust, Inc.
- $7.98 Billion
- Q3 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 3,318 shares of NEO stock, worth $52,391. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,318
Previous 2,331
42.34%
Holding current value
$52,391
Previous $32,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding NEO
# of Institutions
292Shares Held
125MCall Options Held
645KPut Options Held
120K-
Black Rock Inc. New York, NY19.7MShares$311 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$222 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$109 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$104 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$103 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.99B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...